First Time Loading...

Tango Therapeutics Inc
NASDAQ:TNGX

Watchlist Manager
Tango Therapeutics Inc Logo
Tango Therapeutics Inc
NASDAQ:TNGX
Watchlist
Price: 7.44 USD 1.5% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

TNGX Price Targets Summary
Tango Therapeutics Inc

Wall Street analysts forecast TNGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNGX is 17.92 USD with a low forecast of 16.16 USD and a high forecast of 21 USD.

TNGX Lowest Forecast
Wall Street Target
16.16 USD
117% Upside
TNGX Average Forecast
Wall Street Target
17.92 USD
141% Upside
TNGX Highest Forecast
Wall Street Target
21 USD
182% Upside
Lowest
Price Target
16.16 USD
117% Upside
Average
Price Target
17.92 USD
141% Upside
Highest
Price Target
21 USD
182% Upside
Tango Therapeutics Inc Competitors:
Price Targets
BIOA B
BioArctic AB
84% Upside
KRON
Kronos Bio Inc
334% Upside
GRTS
Gritstone bio Inc
588% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
9% Upside
BIOA B
BioArctic AB
84% Upside
KRON
Kronos Bio Inc
334% Upside
GRTS
Gritstone bio Inc
588% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
9% Upside
M
MGX
Metagenomi Inc
205% Upside
MDXG
MiMedx Group Inc
103% Upside
BIOPOR
Bioporto A/S
311% Upside
MRKR
Marker Therapeutics Inc
197% Upside

Revenue
Forecast

Revenue Estimate
Tango Therapeutics Inc

The compound annual growth rate of Tango Therapeutics Inc's revenue for the next 3 years is -5%.

N/A
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Tango Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Tango Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
What are analyst estimates?

See Also

Summary
TNGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TNGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TNGX stock valuation using valuation multiples.
Wall Street Estimates
TNGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TNGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNGX's stock price target?
Price Target
17.92 USD

According to Wall Street analysts, the average 1-year price target for TNGX is 17.92 USD with a low forecast of 16.16 USD and a high forecast of 21 USD.

What is Tango Therapeutics Inc's Revenue forecast?
Projected CAGR
-5%

The compound annual growth rate of Tango Therapeutics Inc's revenue for the next 3 years is -5%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.